iron isomaltoside
Selected indexed studies
- Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials. (JAMA, 2020) [PMID:32016310]
- A prospective, multi-center, randomized comparison of iron isomaltoside 1000 versus iron sucrose in patients with iron deficiency anemia; the FERWON-IDA trial. (Am J Hematol, 2019) [PMID:31243803]
- Intravenous iron supplementation therapy. (Mol Aspects Med, 2020) [PMID:32444112]
_Worker-drafted node — pending editorial review._
Connections
iron isomaltoside is a side effect of
Sources
- Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials. (2020) pubmed
- A prospective, multi-center, randomized comparison of iron isomaltoside 1000 versus iron sucrose in patients with iron deficiency anemia; the FERWON-IDA trial. (2019) pubmed
- Intravenous iron supplementation therapy. (2020) pubmed
- Comparison of iron isomaltoside ferumoxytol with iron sucrose for iron deficiency anemia: a meta-analysis of randomized controlled trials. (2023) pubmed
- Iron Isomaltoside-Induced Anaphylaxis. (2020) pubmed
- Safety of intravenous iron isomaltoside for iron deficiency and iron deficiency anemia in pregnancy. (2020) pubmed
- PMID:38620362 (2022) pubmed
- PMID:33211445 (2020) pubmed
- Iron (III) isomaltoside 1000. (2013) pubmed
- A systematic literature review and indirect comparison of iron isomaltoside and ferric carboxymaltose in iron deficiency anemia after failure or intolerance of oral iron treatment. (2019) pubmed